Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 6:41 pm Unchanged | 2023-12-31 | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 33,527,162 14.400% | 0 (Unchanged) | Filing History |
| 2024-01-31 4:10 pm Sale | 2023-12-31 | 13G | Autolus Therapeutics plc AUTL | Tetragon Financial Management LP | 8,000,000 4.600% | -1,461,883![]() (-15.45%) | Filing History |
| 2023-07-10 5:00 pm Purchase | 2023-06-30 | 13G | Autolus Therapeutics plc AUTL | Paradigm BioCapital Advisors LP | 10,098,584 5.800% | 10,098,584![]() (New Position) | Filing History |
| 2023-03-20 09:13 am Purchase | 2023-03-09 | 13G | Autolus Therapeutics plc AUTL | Tetragon Financial Management LP | 9,461,883 5.500% | 9,461,883![]() (New Position) | Filing History |
| 2023-02-14 5:02 pm Purchase | 2022-12-31 | 13G | Autolus Therapeutics plc AUTL | Nantahala Capital Management, LLC | 7,782,018 4.700% | 3,704,509![]() (+90.85%) | Filing History |
| 2023-02-14 12:09 pm Purchase | 2022-12-31 | 13G | Autolus Therapeutics plc AUTL | Frazier Life Sciences Public Fund, L.P. | 3,746,857 2.200% | 16,200![]() (+0.43%) | Filing History |
| 2023-02-14 12:02 pm Purchase | 2022-12-31 | 13G | Autolus Therapeutics plc AUTL | Armistice Capital, LLC | 10,224,000 5.910% | 10,224,000![]() (New Position) | Filing History |
| 2023-02-14 10:28 am Purchase | 2022-12-31 | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 33,527,162 19.700% | 14,000,000![]() (+71.70%) | Filing History |
| 2023-02-14 08:30 am Unchanged | 2022-12-31 | 13G | Autolus Therapeutics plc AUTL | Deep Track Capital, LP | 15,000,000 8.670% | 0 (Unchanged) | Filing History |
| 2023-02-13 2:49 pm Sale | 2023-02-14 | 13G | Autolus Therapeutics plc AUTL | Capital World Investors | 625,000 0.400% | -2,330,806![]() (-78.86%) | Filing History |
| 2022-12-19 4:11 pm Purchase | 2022-12-09 | 13G | Autolus Therapeutics plc AUTL | Deep Track Capital, LP | 15,000,000 9.030% | 15,000,000![]() (New Position) | Filing History |
| 2022-12-13 4:51 pm Purchase | 2022-12-08 | 13D | Autolus Therapeutics plc AUTL | Blackstone Inc. BX | 23,750,917 14.000% | 2,500,000![]() (+11.76%) | Filing History |
| 2022-12-13 4:50 pm Purchase | 2022-12-09 | 13G | Autolus Therapeutics plc AUTL | Qatar Investment Authority | 15,000,000 9.030% | 15,000,000![]() (New Position) | Filing History |
| 2022-10-05 4:21 pm Purchase | 2022-09-23 | 13D | Autolus Therapeutics plc AUTL | PPF Biotech B.V. | 14,613,275 16.100% | 1,000![]() (+0.01%) | Filing History |
| 2022-02-14 5:03 pm Purchase | 2021-12-31 | 13G | Autolus Therapeutics plc AUTL | Nantahala Capital Management, LLC | 4,077,509 5.600% | 4,077,509![]() (New Position) | Filing History |
| 2022-02-11 12:21 pm Purchase | 2021-12-31 | 13G | Autolus Therapeutics plc AUTL | Syncona Portfolio Ltd | 19,527,162 26.800% | 3,571,428![]() (+22.38%) | Filing History |
| 2021-12-17 2:37 pm Purchase | 2021-12-13 | 13G | Autolus Therapeutics plc AUTL | Frazier Life Sciences Public Fund, L.P. | 3,730,657 5.100% | 3,730,657![]() (New Position) | Filing History |
| 2021-11-16 4:07 pm Purchase | 2021-11-06 | 13D | Autolus Therapeutics plc AUTL | Blackstone Inc. BX | 21,250,917 22.600% | 21,250,917![]() (New Position) | Filing History |
| 2021-06-23 4:00 pm Purchase | 2021-05-18 | 13D | Autolus Therapeutics plc AUTL | PPF Biotech B.V. | 14,612,275 27.900% | 361,255![]() (+2.53%) | Filing History |
| 2021-02-17 5:01 pm Sale | 2021-02-12 | 13D | Autolus Therapeutics plc AUTL | Arix Bioscience plc | 3,319,866 4.800% | -50,000![]() (-1.48%) | Filing History |

